Based on the Hans classification for the cell-of-origin (COO), we found that eight of nine BLS-type DLBCL cases (89%) are of activated B-cell type with a typical immunophenotype of CD10-BCL6-/+MUM1+11. The gene discussed is BCL6; the disease is diffuse large B-cell lymphoma.